Most Read Articles
3 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 3 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, Yesterday

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

Sunlight exposure, low vitamin D intake up risk of vulvovaginal candidiasis

09 Apr 2020

Exposure to sunlight appears to increase the risk of vulvovaginal candidiasis (VVC) development, reveals a recent study in an African population.

An association existed between self-reported low sunlight exposure and increased risk of VVC (odds ratio [OR], 3.38, 95 percent confidence interval, 1.99–5.74). Low and moderate sunlight exposure estimated by outdoor visits also correlated with increased VVC risk.

Sensitivity analysis restricted to matched sunlight exposure data revealed that low and moderate sunlight exposure was associated with ORs of 5.78 (95 percent CI, 2.57–12.99) and 3.53 (95 percent CI, 1.85–6.75), respectively.

Decreasing consumption levels of vitamin D-rich foods further increased the risk of developing VVC (likelihood-ratio test trend: p=0.1382). Furthermore, low and moderate vitamin D intake correlated with a significantly higher risk of VVC in the joint analysis.

“Our findings should be confirmed in prospective studies and clinical trials to strengthen the evidence base for preventive action and to also inform clinical decision making,” the authors said.

This study included 300 females with VVC and 300 controls (females suffering from any condition other than VVC) from three health facilities in Cape Coast, Ghana. A structured questionnaire was used to evaluate sun exposure and a food frequency questionnaire to determine the frequency of consumption of vitamin D-rich foods.

“To date, only two studies have investigated the relationship between vitamin D deficiency and candidiasis in spite of vitamin D’s antimicrobial and immunomodulatory roles,” the researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.
Jairia Dela Cruz, 3 days ago
Following vegan and vegetarian diets, which offer plenty of what is good for health, has been reported to have a downside: an increased risk of depression and anxiety, especially for younger adults.
Pearl Toh, 29 Jun 2020
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Roshini Claire Anthony, Yesterday

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.